Diabetic patient adherence to pathology request completion in primary careNiamh Ramsay A D , Tracey Johnson B and Tony Badrick C
A The University of Notre Dame Australia, School of Medicine Sydney, 160 Oxford Street, Darlinghurst, NSW 2010, Australia.
B Inala Primary Care, 64 Wirraway Parade, Inala, Qld 4077, Australia. Email: email@example.com
C Royal College of Pathologists of Australasia Quality Assurance Programs, Suite 201/8 Herbert Street, St Leonards, NSW 2065, Australia. Email: firstname.lastname@example.org
D Corresponding author. Email: Niamh.email@example.com
Australian Health Review 41(3) 277-282 https://doi.org/10.1071/AH16012
Submitted: 14 January 2016 Accepted: 5 June 2016 Published: 11 August 2016
Objective Little research exists regarding the prevalence of patient non-adherence with completing pathology requests for chronic disease monitoring. The aims of the present study were to determine the extent to which this exists in diabetic patients and to identify possible reasons contributing to this behaviour.
Methods Patients diagnosed with type 2 diabetes mellitus were recruited from three general practices with different demographics. Data were collected by recording demographic patient information at the time of visit. In addition, information regarding patient pathology request adherence and the reasons provided when this was not achieved were also noted. These reasons were compared with preconceptions by medical staff in each practice.
Results General practitioner perceptions of poor patient adherence to pathology requests were confirmed, with rates of non-adherence up to 31% at one practice site. The primary reasons preventing completion of pathology testing included forgetfulness, time poorness, poor health literacy and, in some cases, language barriers.
Conclusion A high proportion of patients do not prioritise the monitoring of their diabetes, potentially because of a lack of understanding of the importance such management has on their health. Further research should be conducted to determine the effect of the implementation of point-of-care testing on patient outcomes in such areas of low non-adherence with disease management.
What is known about the topic? Little quantitative information exists regarding the adherence rate of patients to pathology request completion. Without up-to-date pathology results, a barrier is created, preventing accurate medical treatment of the patient’s condition because the doctor cannot ascertain a full picture of the patient’s current disease state at the time of consultation.
What does this paper add? This paper quantifies the rate of non-adherence among three diabetic patient groups at different practice sites, taking into account patient and site demographics. It also confirms patient non-adherence to timely pathology request completion as a prevalent issue of concern at all practice sites recruited. In addition, it looks at reasons why this issue exists as a means of addressing the problem in the future.
What are the implications for practitioners? This research may aid practitioners in addressing such issues at a local level within general practice, because reasons creating barriers to successful completion of pathology requests have been identified and potential solutions suggested.
References Plebani M. Does POCT reduce the risk of error in laboratory testing? Clin Chim Acta 2009; 404 59–64.
| Does POCT reduce the risk of error in laboratory testing?CrossRef | 1:CAS:528:DC%2BD1MXmtlOitrg%3D&md5=038a9a21805390bebb0b9d250ad5d853CAS | 19298804PubMed |
 Bayram C, Britt H, Miller G, Valenti L. School of Public Health. Evidence–practice gap in GP pathology test ordering: a comparison of BEACH pathology data and recommended testing. The University of Sydney; 2009.
 St John A. The evidence to support point-of-care testing. Clin Biochem Rev 2010; 31 111–9.
| 24150515PubMed |
 Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999; 22 1785–9.
| Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.CrossRef | 1:STN:280:DC%2BD3c%2Fhtlegsw%3D%3D&md5=765d763459ff0481eb22b4a1617a6ed2CAS | 10546008PubMed |
 Marrero DG, Vandagriff JL, Gibson R, Fineberg SE, Fineberg NS, Hiar CE, Crowley LE. Immediate HbA1c results. Performance of new HbA1c system in pediatric outpatient population. Diabetes Care 1992; 15 1045–9.
| Immediate HbA1c results. Performance of new HbA1c system in pediatric outpatient population.CrossRef | 1:STN:280:DyaK38zntFWgtg%3D%3D&md5=550ecaf2a91675d48e574e0972e6910bCAS | 1505308PubMed |
 Schwartz KL, Monsur J, Hammad A, Bartoces MG, Neale AV. Comparison of point of care and laboratory HbA1c analysis: a MetroNet study. J Am Board Fam Med 2009; 22 461–3.
| Comparison of point of care and laboratory HbA1c analysis: a MetroNet study.CrossRef | 19587262PubMed |
 Khunti K, Stone MA, Burden AC, Turner D, Raymond NT, Burden M, Baker R. Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus. Br J Gen Pract 2006; 56 511–7.
| 16834877PubMed |
 Swan W. Australia to 2050: future challenges. CanPrint Communications Pty Ltd; 2010.
 The Royal Australian College of General Practitioners, Diabetes Australia. General practice management of type 2 diabetes, 2014–2015. Melbourne; The Royal Australian College of General Practitioners and Diabetes Australia 2014.
 National Diabetes Strategy Advisory Group. A strategic framework for action: consultation paper for the development of the Australian National Diabetes Strategy. 2015. Available at: http://apo.org.au/node/54128 [verified 2 June 2015].
 Australian Institute of Health and Welfare. Risk factors contributing to chronic disease. 2012. Available at: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421546 [verified 11 July 2014].
 Australian Bureau of Statistics (ABS). Census of population and housing: socio-economic indexes for areas, vol. SEIFA 2011. Canberra: ABS; 2013. Available at: http://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/0/22CEDA8038AF7A0DCA257B3B00116E34/$File/2033.0.55.001%20seifa%202011%20technical%20paper.pdf [verified 11 July 2014].
 Harrison C, Britt H, Miller G, Henderson J. Multi-morbidity. Aust Fam Physician 2013; 42 845
| 24324982PubMed |
 King P, Peacock I, Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol 1999; 48 643–8.
| The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes.CrossRef | 1:STN:280:DC%2BD3c%2FmtlKltg%3D%3D&md5=51b104c7876d5a055aac11c70d154802CAS | 10594464PubMed |
 Australian Commission on Safety and Quality in Health Care. Health Literacy National Statement. 2014. Available at: http://www.safetyandquality.gov.au/wp-content/uploads/2014/08/Health-Literacy-National- Statement.pdf [verified 9 June 2016].
 National Health Performance Authority. Healthy communities: frequent GP attenders and their use of health services in 2012–13. 2015.
 Epner PL. Achieving the promise of point-of-care testing. Point Care 2014; 13 112–13.
| Achieving the promise of point-of-care testing.CrossRef |
 Lewandrowski K. Point-of-care testing: an overview and a look to the future (circa 2009, United States). Clin Lab Med 2009; 29 421–32.
| Point-of-care testing: an overview and a look to the future (circa 2009, United States).CrossRef | 19840677PubMed |
 Shephard MD, Gill J. The National QAAMS program: a practical example of PoCT working in the community. Clin Biochem Rev 2010; 31 105–9.
| 24150514PubMed |
 Shephard MD, Mazzachi BC, Shephard AK, McLaughlin KJ, Denner B, Barnes G. The impact of point of care testing on diabetes services along Victoria’s Mallee Track: results of a community-based diabetes risk assessment and management program. Rural Remote Health 2005; 5 371
| 16026194PubMed |
 Laurence C, Gialamas A, Yelland L, Bubner T, Glastonbury B, Beilby J. Point of Care Testing in General Practice Trial. Canberra: Department of Health and Ageing; 2009.
 Tirimacco R. Evolution of Point-of-Care Testing in Australia. Clin Biochem Rev 2010; 31 75–80.
| 24150508PubMed |